Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.510
-0.020 (-0.79%)
Oct 17, 2025, 4:10 PM AEST
Australian Clinical Labs Revenue
In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27 million AUD with 6.45% growth. Australian Clinical Labs had revenue of 372.1 million in the half year ending June 30, 2025, with 10.49% growth.
Revenue
741.27M
Revenue Growth
+6.45%
P/S Ratio
0.66
Revenue / Employee
157.72K
Employees
4,700
Market Cap
488.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 741.27M | 44.90M | 6.45% |
| Jun 30, 2024 | 696.37M | -704.00K | -0.10% |
| Jun 30, 2023 | 697.07M | -298.53M | -29.99% |
| Jun 30, 2022 | 995.60M | 348.90M | 53.95% |
| Jun 30, 2021 | 646.70M | 156.13M | 31.83% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |